Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Transformation of NSCLC to SCLC after 1st- and 3rd-generation EGFR-TKI resistance and response to EP regimen and erlotinib: 2 CARE-compliant case reportsMedicine (Baltimore), 2021-03, Vol.100 (10), p.e25046-e25046 [Peer Reviewed Journal]Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. ;Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. 2021 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000025046 ;PMID: 33725888Full text available |
|
2 |
Material Type: Article
|
Correlation of iodine uptake and perfusion parameters between dual-energy CT imaging and first-pass dual-input perfusion CT in lung cancerMedicine (Baltimore), 2017-07, Vol.96 (28), p.e7479-e7479 [Peer Reviewed Journal]Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. 2017 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000007479 ;PMID: 28700488Full text available |
|
3 |
Material Type: Article
|
Muscle mass and association to quality of life in non‐small cell lung cancer patientsJournal of cachexia, sarcopenia and muscle, 2017-10, Vol.8 (5), p.759-767 [Peer Reviewed Journal]2017 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of the Society on Sarcopenia, Cachexia and Wasting Disorders ;2017 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of the Society on Sarcopenia, Cachexia and Wasting Disorders. ;2017. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;info:eu-repo/semantics/openAccess ;ISSN: 2190-5991 ;ISSN: 2190-6009 ;EISSN: 2190-6009 ;DOI: 10.1002/jcsm.12206 ;PMID: 28493418Full text available |
|
4 |
Material Type: Article
|
The relationship between NLR/PLR/LMR levels and survival prognosis in patients with non-small cell lung carcinoma treated with immune checkpoint inhibitorsMedicine (Baltimore), 2022-01, Vol.101 (3), p.e28617-e28617 [Peer Reviewed Journal]Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. ;Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. 2022 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000028617 ;PMID: 35060536Full text available |
|
5 |
Material Type: Article
|
C-terminal binding protein-2 is a prognostic marker for lung adenocarcinomasMedicine (Baltimore), 2020-07, Vol.99 (31), p.e20076-e20076 [Peer Reviewed Journal]Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. 2020 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000020076 ;PMID: 32756072Full text available |
|
6 |
Material Type: Article
|
Characterisation of gut, lung, and upper airways microbiota in patients with non-small cell lung carcinoma: Study protocol for case-control observational trialMedicine (Baltimore), 2018-12, Vol.97 (50), p.e13676-e13676 [Peer Reviewed Journal]Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. 2018 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000013676 ;PMID: 30558074Full text available |
|
7 |
Material Type: Article
|
Risk factors of postoperative acute lung injury following lobectomy for nonsmall cell lung cancerMedicine (Baltimore), 2019-03, Vol.98 (13), p.e15078 [Peer Reviewed Journal]Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. 2019 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/md.0000000000015078 ;PMID: 30921242Full text available |
|
8 |
Material Type: Article
|
Feasibility of early multimodal interventions for elderly patients with advanced pancreatic and non‐small‐cell lung cancerJournal of cachexia, sarcopenia and muscle, 2019-02, Vol.10 (1), p.73-83 [Peer Reviewed Journal]2018 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of the Society on Sarcopenia, Cachexia and Wasting Disorders ;2018 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of the Society on Sarcopenia, Cachexia and Wasting Disorders. ;2019. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2190-5991 ;EISSN: 2190-6009 ;DOI: 10.1002/jcsm.12351 ;PMID: 30334618Full text available |
|
9 |
Material Type: Article
|
Dual-scale categorization based deep learning to evaluate programmed cell death ligand 1 expression in non-small cell lung cancerMedicine (Baltimore), 2021-05, Vol.100 (20), p.e25994-e25994 [Peer Reviewed Journal]Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. ;Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. 2021 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000025994 ;PMID: 34011092Full text available |
|
10 |
Material Type: Article
|
Expression and prognostic impact of CD49b in human lung cancerMedicine (Baltimore), 2022-02, Vol.101 (6), p.e28814-e28814 [Peer Reviewed Journal]Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. ;Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. 2022 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000028814 ;PMID: 35147120Full text available |
|
11 |
Material Type: Article
|
Association between pulmonary artery to aorta diameter ratio with pulmonary hypertension and outcomes in diffuse cystic lung diseasesMedicine (Baltimore), 2021-06, Vol.100 (25), p.e26483-e26483 [Peer Reviewed Journal]Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. ;Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. 2021 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000026483 ;PMID: 34160461Full text available |
|
12 |
Material Type: Article
|
Small-cell lung cancer transformation from EGFR-mutant adenocarcinoma after EGFR-TKIs resistance: A case reportMedicine (Baltimore), 2021-08, Vol.100 (32), p.e26911-e26911 [Peer Reviewed Journal]Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. ;Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. 2021 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000026911 ;PMID: 34397927Full text available |
|
13 |
Material Type: Article
|
Effective treatment with icotinib in advanced lung adenocarcinoma harboring rare EGFR mutation G719A/L833V: A case reportMedicine (Baltimore), 2022-08, Vol.101 (33), p.e30080-e30080 [Peer Reviewed Journal]Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. ;Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. 2022 ;ISSN: 1536-5964 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000030080 ;PMID: 35984165Full text available |
|
14 |
Material Type: Article
|
Prognostic significance of PD-L1 in advanced non-small cell lung carcinomaMedicine (Baltimore), 2020-11, Vol.99 (45), p.e23172 [Peer Reviewed Journal]Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. 2020 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000023172 ;PMID: 33158004Full text available |
|
15 |
Material Type: Article
|
Lung carcinoma with diffuse cysts repeatedly misdiagnosed as pulmonary infections and lymphoid interstitial pneumonia: A case reportMedicine (Baltimore), 2024-02, Vol.103 (5), p.e37002-e37002 [Peer Reviewed Journal]Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc. ;Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc. 2024 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000037002 ;PMID: 38306516Full text available |
|
16 |
Material Type: Article
|
Mesenchymal cystic hamartoma of the lung: A case reportMedicine (Baltimore), 2022-01, Vol.101 (1), p.e28242-e28242 [Peer Reviewed Journal]Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. ;Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. 2022 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000028242 ;PMID: 35029876Full text available |
|
17 |
Material Type: Article
|
Concomitant lung adenocarcinoma and pulmonary cryptococcosis confirmed by pathologic examinationsMedicine (Baltimore), 2019-12, Vol.98 (50), p.e18316-e18316 [Peer Reviewed Journal]Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. 2019 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000018316 ;PMID: 31852116Full text available |
|
18 |
Material Type: Article
|
Lung adenocarcinoma harboring complex EML4-ALK fusion and BRAF V600E co-mutation responded to alectinibMedicine (Baltimore), 2022-10, Vol.101 (40), p.e30913-e30913 [Peer Reviewed Journal]Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. ;Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. 2022 ;ISSN: 1536-5964 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000030913 ;PMID: 36221356Full text available |
|
19 |
Material Type: Article
|
Systemic immune-inflammation index is a promising noninvasive marker to predict survival of lung cancer: A meta-analysisMedicine (Baltimore), 2019-01, Vol.98 (3), p.e13788-e13788 [Peer Reviewed Journal]Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. 2019 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000013788 ;PMID: 30653090Full text available |
|
20 |
Material Type: Article
|
C-reactive protein is a significant predictor of improved survival in patients with advanced non-small cell lung cancerMedicine (Baltimore), 2019-06, Vol.98 (26), p.e16238-e16238 [Peer Reviewed Journal]Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. 2019 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000016238 ;PMID: 31261584Full text available |